While the Media has been focusing merely on Piramal’s cash pile, and have rather been supremely obsessive about it, Ajay Piramal has had most of his investments show green shoots already. From approval of 2 drugs by the USFDA and the EU and IndiaREIT growing to manage over 7,500cr the media has missed a lot…
Read MorePiramal Enterprises – FDA Approves Florbetaben
Piramal Imaging ( Subsidiary of Piramal Enterprises) has made two major acquisitions, BST CarGel for 30cr in 2011 from BioSynTech and a molecular imaging Portfolio from Bayer in 2012 for an undisclosed amount. CarGel received approval in the EU in 2012 and is still awaiting approval from the FDA. For an acquisition price of 30cr…
Read More